News

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'

When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully

Annual Jones Lang LaSalle report ranks US clusters, looks at international activity

Patients, physicians and pharmacists signal their support of copay cards in Alliance Life Sciences study

Number of cases opened by FDA's Office of Criminal Investigations (OCI) triples to 170

As the business grows at double-digit rates, representing its interests becomes its own business opportunity

Like the other war on drugs, there's no end in sight

Microneedles and 'active' patches extend the reach of transdermal applications

Partnership brings pharma messaging into another EHR vendor

The agency is not receiving timely reports from industry sponsors, and is behind in its own evaluation programs

New study outlines the scope of falsified pharmaceuticals and diverted trade globally, but also highlights the international-policy complications

National Conference of Pharmaceutical Organizations (NCPO) seeks national standards

Cardinal will beef up its direct-to-home distribution channels

Patients, physicians and pharmacists signal their support of copay cards in Alliance Life Sciences study

Web design is tailored to tablets, with scrolling screens and ‘native content’ for advertisers

A shift from datalogging as a passive monitor to a shipment validation

Next addition is 'already being planned' says divisional VP, Bill Hook

Virtuwell, operated by a MN healthcare provider, has expanded to three states

Industry data collection to begin Aug. 1, with a first report to CMS on March 31, 2014

As the business grows at double-digit rates, representing its interests becomes its own business opportunity

Number of cases opened by FDA's Office of Criminal Investigations (OCI) triples to 170

'Scriptbags' and 'Rep in a Box' are about to be tested in pharma sample distribution

Data compiled by the Worldwide Network for Blood and Marrow Transplantation (WNBMT) measures the landmark; some 70 diseases are now treated by the therapy

Branded as Orca 2.0, the line features advanced phase-change material and proprietary software design

New emphasis will be placed on last-mile courier holdups

Arrangement expands Cryoport's service agreement with the lab